SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Blueprint Medicines Corporation (BPMC)

BPMC RSS Feed
Add BPMC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/5/2016 12:43:36 PM - Followers: 6 - Board type: Free - Posts Today: 0

Blueprint Medicines is a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling Blueprint to rapidly develop potent highly selective compounds against clear genomic driver targets.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BPMC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BPMC News: Statement of Changes in Beneficial Ownership (4) 03/20/2017 04:22:34 PM
BPMC News: Blueprint Medicines Announces Enrollment of First Patient in Phase 1 Clinical Trial for BLU-667 03/20/2017 04:01:00 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 03/16/2017 05:39:07 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 03/16/2017 05:38:13 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 03/16/2017 05:36:01 PM